Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10963859 | Vaccine | 2015 | 6 Pages |
Abstract
This regional overview of A[H1N1]pdm vaccine safety data in LAC estimated the rate of serious ESAVI at lower levels than other studies. However, the ESAVI diagnosis distribution is comparable to the published literature. Lessons learned can be applied in the response to future pandemics.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
A.M. Ropero-Álvarez, A. Whittembury, P. Bravo-Alcántara, H.J. Kurtis, M.C. Danovaro-Holliday, M. Velandia-González,